Loading company…
SynchNeuro develops medical devices for diagnosing and treating neurological disorders.
Founded in 2021 and based in Philadelphia, US, SynchNeuro develops medical devices for neurological health and clinical use. It raised USD 3 million in seed funding in August 2025, led by Boomerang Ventures. The company plans to advance EEG-based technology for real-time monitoring of blood glucose and other health indicators.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in